Literature DB >> 21193982

Re: sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia.

Gaurav N Kaushik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193982     DOI: 10.1007/s00213-010-2155-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  6 in total

1.  Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice.

Authors:  Aditi Aggarwal; Vaibhav Gaur; Anil Kumar
Journal:  Life Sci       Date:  2010-04-28       Impact factor: 5.037

2.  Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test.

Authors:  Andréa D E Zomkowski; Daiane Engel; Nelson H Gabilan; Ana Lúcia S Rodrigues
Journal:  Eur Neuropsychopharmacol       Date:  2010-11       Impact factor: 4.600

3.  Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression.

Authors:  Nico Liebenberg; Brian H Harvey; Linda Brand; Christiaan B Brink
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

4.  Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.

Authors:  Shahin Akhondzadeh; Raofeh Ghayyoumi; Farzin Rezaei; Bahman Salehi; Amir-Hossein Modabbernia; Azad Maroufi; Gholam-Reza Esfandiari; Mehrangiz Naderi; Fariba Ghebleh; Mina Tabrizi; Shams-Ali Rezazadeh
Journal:  Psychopharmacology (Berl)       Date:  2010-10-15       Impact factor: 4.530

Review 5.  The role of phosphodiesterases in schizophrenia : therapeutic implications.

Authors:  Judith A Siuciak
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 6.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.